全文获取类型
收费全文 | 362篇 |
免费 | 23篇 |
专业分类
儿科学 | 3篇 |
妇产科学 | 1篇 |
基础医学 | 19篇 |
口腔科学 | 1篇 |
临床医学 | 18篇 |
内科学 | 183篇 |
皮肤病学 | 5篇 |
神经病学 | 12篇 |
特种医学 | 3篇 |
外科学 | 53篇 |
综合类 | 13篇 |
预防医学 | 48篇 |
药学 | 21篇 |
肿瘤学 | 5篇 |
出版年
2023年 | 5篇 |
2022年 | 3篇 |
2021年 | 7篇 |
2020年 | 6篇 |
2019年 | 5篇 |
2018年 | 9篇 |
2017年 | 9篇 |
2016年 | 16篇 |
2015年 | 3篇 |
2014年 | 14篇 |
2013年 | 15篇 |
2012年 | 24篇 |
2011年 | 17篇 |
2010年 | 9篇 |
2009年 | 10篇 |
2008年 | 21篇 |
2007年 | 12篇 |
2006年 | 19篇 |
2005年 | 18篇 |
2004年 | 22篇 |
2003年 | 15篇 |
2002年 | 15篇 |
2001年 | 10篇 |
2000年 | 9篇 |
1999年 | 12篇 |
1998年 | 2篇 |
1997年 | 4篇 |
1994年 | 1篇 |
1992年 | 8篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 5篇 |
1987年 | 7篇 |
1986年 | 10篇 |
1985年 | 6篇 |
1984年 | 2篇 |
1983年 | 4篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1972年 | 2篇 |
1966年 | 1篇 |
排序方式: 共有385条查询结果,搜索用时 203 毫秒
1.
2.
A modified design is described for the skin graft board, which improves its performance when used in conjunction with the skin graft knife. 相似文献
3.
4.
Mahaffey KR 《Current opinion in neurology》2000,13(6):699-707
Clinically evident neurologic damage from methylmercury exposure was well described following poisoning episodes in Japan and Iraq several decades ago. Paresthesias have been considered to be an early effect; however, additional data raise questions about whether this is the most sensitive adverse effect among adults. Fetuses are considered the most sensitive subpopulation because of the vulnerability of the developing nervous system. Over the past 5 years questions have been raised about what is an appropriate level of exposure for sensitive groups. A recent evaluation by a committee for the US National Research Council found that 0.1 microg/kg body weight per day is a scientifically justified level of methylmercury exposure for maternal-fetal pairs. The conclusions of this report and other issues are discussed in the present review. Because of anthropogenic release of mercury into the environment, methylmercury exposure from fish consumption is a pathway that is of increasing concern. 相似文献
5.
Megumi Oshima Meg J. Jardine Rajiv Agarwal George Bakris Christopher P. Cannon David M. Charytan Dick de Zeeuw Robert Edwards Tom Greene Adeera Levin Soo Kun Lim Kenneth W. Mahaffey Bruce Neal Carol Pollock Norman Rosenthal David C. Wheeler Hong Zhang Bernard Zinman Hiddo J.L. Heerspink 《Kidney international》2021,99(4):999-1009
- Download : Download high-res image (391KB)
- Download : Download full-size image
6.
Yong Li Carlos Gorbea David Mahaffey Martin Rechsteiner Robert Benezra 《Proceedings of the National Academy of Sciences of the United States of America》1997,94(23):12431-12436
Cell cycle progression is monitored by checkpoint mechanisms that ensure faithful duplication and accurate segregation of the genome. Defects in spindle assembly or spindle-kinetochore attachment activate the mitotic checkpoint. Once activated, this checkpoint arrests cells prior to the metaphase-anaphase transition with unsegregated chromosomes, stable cyclin B, and elevated M phase promoting factor activity. However, the mechanisms underlying this process remain obscure. Here we report that upon activation of the mitotic checkpoint, MAD2, an essential component of the mitotic checkpoint, associates with the cyclin B-ubiquitin ligase, known as the cyclosome or anaphase-promoting complex. Moreover, purified MAD2 causes a metaphase arrest in cycling Xenopus laevis egg extracts and prevents cyclin B proteolysis by blocking its ubiquitination, indicating that MAD2 functions as an inhibitor of the cyclosome. Thus, MAD2 links the mitotic checkpoint pathway to the cyclin B destruction machinery which is critical in controlling the metaphase-anaphase transition. 相似文献
7.
Wei-Ching Chang Padma Kaul Yuling Fu Cynthia M Westerhout Christopher B Granger Kenneth W Mahaffey Lars Wallentin Frans Van de Werf Paul W Armstrong 《European heart journal》2006,27(4):419-426
AIMS: To demonstrate the feasibility and clinical utility of developing dynamic risk assessment models for ST-segment elevation myocardial infarction (STEMI) patients. METHODS AND RESULTS: In 6066 STEMI patients enrolled in the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial with complete electrocardiographic data, we assessed the probability of 30-day mortality over the following forecasting periods beginning at day 0 (baseline), 3 h, day 2, and day 5 using multiple-logistic regression. These models were validated and simplified in independent samples of 1622 similar fibrinolytic-treated patients from the ASSENT-3 PLUS trial and in 814 STEMI patients undergoing primary percutaneous coronary intervention in the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. The discriminatory power of these predictive models, from baseline to day 5, was excellent (c-statistics 0.80 to 0.87); and their predictive ability was supported by strong gradients in mortality outcomes as the risk score increased. Dynamic modelling also provided information on the change in prognosis over time which may be used to advise more appropriate therapeutic decisions, e.g. the identification of high-risk patients for possible co-interventions. CONCLUSION: Dynamic modelling for STEMI patients enhances the risk assessment and stratification and should provide valuable ongoing guidance for their management. 相似文献
8.
9.